
Opinion|Videos|January 19, 2024
Key Takeaways for Patients With Myelofibrosis
Author(s)Christine Cooper, RN, BSN, Aaron Gerds, MD, MS
Patients with myelofibrosis should reflect on their personal priorities and quality of life goals, understand the range of available JAK inhibitor treatment options, and openly communicate with their doctor to arrive at a shared decision for managing their disease.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
3
New Combination Treatment Approach Studied in Pancreatic Cancer
4
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
5
